IonMAN Trial- First in Human Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System

NCT05364697 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Stenosis
Coronary Disease
Non-ST Elevated Myocardial Infarction
Cardiovascular Diseases

Interventions

DEVICE: IoNIR Ridaforolimus-Eluting Coronary Stent System

Sponsor

Medinol Ltd.